Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Pancreatic Neoplasms 5Neoplasm Metastasis 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Radiation Injuries 1Precancerous Conditions 1Papillomavirus Infections 1Pancreatic Adenocarcinoma 1Ovarian Neoplasms 1Neoplasms 1Head and Neck Neoplasms 1Gallbladder Neoplasms 1Fallopian Tube Neoplasms 1Cholangiocarcinoma 1Carcinoma 1Anatomic Stage II Breast Cancer AJCC v8 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1Adenocarcinoma 1

Interventions

trastuzumab biosimilar HLX02 1pertuzumab 1Trastuzumab 1Taxes 1Surgical Procedures, Operative 1Radiotherapy 1Radiation 1Paclitaxel 1PF-05280014 1Ontruzant 1Ogivri 1Mastectomy, Segmental 1Mastectomy 1Magnetic Resonance Spectroscopy 1Fluorodeoxyglucose F18 1Drug Therapy 1Docetaxel 1Albumin-Bound Paclitaxel 1Ado-Trastuzumab Emtansine 12C4 antibody 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Anatomic Stage II Breast Cancer AJCC v8 × Albumin-Bound Paclitaxel × Clear all
NCT04266249 2026-05-05

CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy

Eastern Cooperative Oncology Group

Phase 2 Active not recruiting
2,175 enrolled
Breast

Anatomic Stage II Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡